New Treatment Options Using 5-HT3 Receptor Antagonists in Rheumatic Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|6|18|2035-2042

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.6, Iss.18, 2006-09, pp. : 2035-2042

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent progress in 5-HT6 receptor antagonists for the treatment of CNS diseases

By Slassi Abdelmalik   Isaac Methvin   O’Brien Anne  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 513-527

Informa Healthcare

Access to resources Recommend Favorite

5-HT3 receptor antagonists

By Higgins G.A.   Kilpatrick G.J.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2183-2188

Informa Healthcare

Access to resources Recommend Favorite

Advances in use of the 5-HT3 receptor antagonists

By Walton S.M.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 207-223

Informa Healthcare

Access to resources Recommend Favorite

Are All 5-HT3 Receptor Antagonists the Same?

By McNulty Robert  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 1, 2007-01 ,pp. : 35-43

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

New benzimidazole derivatives: selective and orally active 5-HT 3 receptor antagonists

By Pascual D.   Giron R.   Alsasua A.   Benhamu B.   Lopez-Rodrguez M.L.   Martn M.I.  

European Journal of Pharmacology, Vol. 462, Iss. 1, 2003-02 ,pp. : 99-107

Elsevier

Access to resources Recommend Favorite